Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

Clinical trial NCT01926197 · COMPLETED

Trial details

NCT number: NCT01926197
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2013-08-14
Primary completion: 2021-09-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.